Tocilizumab in MOG-antibody spectrum disorder: a case report

ConclusionOur observations suggest that TCZ could induce clinico-radiologic improvements, which make it as an option for the treatment of MOG-SD.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research